Hormone linked to good hearing as we age
Editor: Researchers have discovered that the presence of a particular
hormone is related how well a person retains her hearing as she ages.
Here's the press release from the University of Rochester Medical Center
~~~~~~~~~~~~~~~~~
Researchers have linked a hormone known to adjust levels of key brain
chemicals to the quality of our hearing as we age. The more of the
hormone that older people have in their bloodstream, the better their
hearing is, and the less of the hormone, the worse their hearing is. The
hormone, aldosterone, is known to regulate kidney function and also
plays a role in controlling levels of two crucial signaling chemicals in
the nervous system, potassium and sodium.
For nerves to send signals crisply and work properly, potassium and
sodium must be in precise proportion, without any disruption in the
molecular channels or gates through which they move. Levels of potassium
are particularly crucial in the sensitive inner ear, where fluid rich in
potassium plays a central role in converting sounds into signals that
the nervous system recognizes.
The team of scientists in Rochester, N.Y., put 47 healthy men and
women between the ages of 58 and 84 through a battery of sophisticated
hearing tests. Scientists also measured their blood levels of
aldosterone, which is known to drop as people age. They found that
people with severe hearing loss had on average about half as much
aldosterone in their bloodstream as their counterparts with normal
hearing. The researchers noted, however, that the levels of aldosterone
found in all the participants is considered normal, and that no patients
or physicians should consider altering aldosterone levels without more
research.
The findings come from researchers at the International Center for
Hearing and Speech Research (ICHSR), a group funded by the National
Institute on Aging that is recognized as a leader in research on
age-related hearing loss. The center includes scientists from the
National Technical Institute for the Deaf at Rochester Institute of
Technology and neuroscientists from the University of Rochester.
"The inner ear is especially sensitive to any disruption in
potassium levels," said Robert D. Frisina, Ph.D., professor of
Otolaryngology at the University of Rochester Medical Center and an
adjunct professor at Rochester Institute of Technology. "We know
that potassium levels in the inner ear seem to decrease as we age and
that these falling levels play a role in age-related hearing loss, and
we also know that blood levels of aldosterone generally decrease with
age.
"We found a direct link between blood levels of aldosterone and
the ability of people to hear normally as they age. Depressed hormone
levels may hurt hearing both in the inner ear and the part of the brain
used for hearing. More research is needed, however, to understand the
precise role that aldosterone plays - for instance, whether it's a cause
of failed hearing, or whether it's symptomatic. Before we understand the
issue more fully, people should not worry about their aldosterone levels
or look to boost the amount in their bloodstream."
The team led by Frisina published its results in the November issue
of the journal Hearing Research. This week at the annual international
meeting of the Association for Research in Otolaryngology in Baltimore,
the team presented its latest results showing just how important
potassium regulation is to age-related hearing loss.
In Baltimore, Otolaryngology medical resident Jared Spencer, M.D.,
presented results from "knockout" mice whose genes controlling
the potassium channels in the inner ear don't function properly, and
confirmed that malfunctioning potassium channels are central to
age-related hearing loss, or presbycusis. The channels are highly
concentrated in a part of the brain that plays an important role
providing feedback from the brain to the ears. Frisina's team previously
discovered that the feedback system is one of the first things to go
wrong in age-related hearing loss, often declining in people who are in
their 40s and 50s, usually before they even realize their hearing is
declining.
"We are now working out some of the underlying biology about how
the decline occurs," said Frisina. "We have evidence that
these potassium channels may play an important role in the failure of
the feedback system, which is a big part of age-related hearing
loss."
Nearly everyone wrestles with failing hearing at some point. While
some people suffer from hearing damage as a result of exposure to loud
noise, or from other causes such as the side effects of some
medications, for many people hearing problems occur with no known cause.
Some people notice problems in their 40s and 50s, but the process
becomes very noticeable for most people in their 60s and older.
Frisina said that until the biology of the problem is better
understood, the best advice for people concerned about hearing loss is
to limit exposure to loud, damaging noise and to medications that are
toxic to the ears. He also counsels people to eat healthy and to
exercise - "all those things you know you should be doing to stay
healthy with age," he said.
Meanwhile, his team is looking at the possibility of using gene
therapy to try to correct the problem. It may be possible some day to
modify a person's inner ear to correct the potassium imbalance that is
central to hearing loss. Such an approach might also address the biggest
cause of congenital deafness, which involves a genetic mutation that
mucks up the potassium balance in the inner ear.
The new findings come from a research group founded by Robert
Frisina's father, D. Robert Frisina, Ph.D., founding director of NTID,
who heads one of the largest research groups in the world studying
age-related hearing loss. The group has attracted top researchers from
around the world to come together to study the problem. Members of the
group, which numbers more than two dozen, hail from Egypt, Brazil,
Russia, China, Korea, India, and the United States.
In addition to Frisina, Frisina and Spencer, the team includes
post-doctoral research associate Sherif Tadros, M.D., of both the
University and NTID, who is first author of the Hearing Research paper;
research nurse Susan Frisina of both NTID and the University;
audiologist Frances Mapes of NTID; and otolaryngologist Xiaozia Zhu,
M.D., of the University.